Archive for 'Biopharmacy'
Rosellini Scientific Benelux SA Joins Walloon Region Consortium to Help Develop Implant System for Glaucoma Treatment
An exciting new medtech player in Belgium’s Walloon Region – Rosellini Scientific Benelux SA (RSB) – joins the consortium to develop a novel implant system for treating and monitoring glaucoma. The 4-partner consortium, led by iSTAR [...]
An article in the Japanese press is praising the quality of research in cellular therapy at the UCL within the laboratory of Prof. Etienne Sokal and at Louvain-born spin-off Promethera Biosciences. The article on regenerative medicine, [...]
Cardio3 BioSciences named Trends-Tendances Business Tour 2013 Most Innovative Company for Brabant Walloon
Cardio3 BioSciences (Mont-Saint-Guibert, Belgium) has been named winner of the Trends-Tendances Business Tour 2013 Award in the “Innovation” category for the Brabant Walloon region. The Business Tour showcases three companies in each province in the country in [...]
Since January of 2013, a commercial subsidiary of Ipratech(Mons, Belgium) has been up and running on America’s east coast. Thanks to the support of Sofinex, (subsidiary of the group Sowalfin,Wallonnia Region), a group endorsing the internationalization [...]
Sirris has been using additive manufacturing technologies, known as “3D printing” to consumers, for nearly 25 years. Today, this research centre located in Gosselies (a hot-spot for health biotechnologies in Wallonia, Belgium) reaches another level and [...]
Latest news from Mont-Saint-Guibert, Belgium – Cardio3 BioSciences SA has recently announced that it is considering raising new funds through an Initial Public Offering on NYSE Euronext Brussels and NYSE Euronext Paris. This is an update to the [...]
Cardio3 BioSciences’ publishes Phase II trial results for stem cell therapy treatment in the JACC and increases its equity by €19 million.
Two exciting new announcements have recently been made by Belgian-based biotechnology company Cardio3 BioSciences(Mont-Saint Guibert, Wallonia). In early April the company announced the publication of Phase II trial results for stem cell therapy C-Cure® in the [...]
Updating on the February 15th post, some exciting new developments have recently occurred that further strengthen Bone Therapeutics’ cell product manufacturing capabilities. Following a successful Series D fundraising round, Bone Therapeutics, alongside the Walloon Region and private [...]
Mithra pharmaceuticals: making the most of its Belgian homeland with new Liège investment and creation of 160 jobs
François Fornieri, founder and CEO of Mithra Pharmaceuticals and former manager of the year in 2011(Trends-Tendances), recently announced he will be making an important €40-50 million long-term investment in Liège that is expected to create 160 [...]
DNAlytics, a Belgian-based SME, introduces new diagnostic solution to help rheumatologists and orthopedic surgeons identify rheumatoid arthritis at the early onset
In keeping in line with their intent to develop a culture of innovation with a focus on the patient; and to be the reference partner in data analysis for predictive and personalized medicine for the European [...]